Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-07
DOI
10.1038/s41598-017-00889-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
- (2016) Semir Beyaz et al. NATURE
- Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease
- (2016) Manuel Vázquez-Carrera TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease
- (2015) Michal Pawlak et al. JOURNAL OF HEPATOLOGY
- The forgotten members of the glucagon family
- (2014) Dominique Bataille et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- HDL-targeted therapies: progress, failures and future
- (2014) Bronwyn A. Kingwell et al. NATURE REVIEWS DRUG DISCOVERY
- Harnessing the benefits of PPARβ/δ agonists
- (2013) Louise S. Mackenzie et al. LIFE SCIENCES
- Lipid Effects of Peroxisome Proliferator-Activated Receptor-Δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol
- (2012) Eric J. Olson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Activation of intestinal peroxisome proliferator-activated receptor- increases high-density lipoprotein production
- (2012) S. Colin et al. EUROPEAN HEART JOURNAL
- Effect of antibiotic treatment on fat absorption in mice with cystic fibrosis
- (2012) Marjan Wouthuyzen-Bakker et al. PEDIATRIC RESEARCH
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor agonist
- (2012) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
- (2011) Mehdi Daoudi et al. GASTROENTEROLOGY
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Both the Peroxisome Proliferator-Activated Receptor δ Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol
- (2009) François Briand et al. CTS-Clinical and Translational Science
- Scavenger Receptor BI-mediated Selective Uptake Is Required for the Remodeling of High Density Lipoprotein by Endothelial Lipase
- (2009) Niels Nijstad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
- (2009) Carlos L. J. Vrins et al. JOURNAL OF LIPID RESEARCH
- Targeted Genetic Disruption of Peroxisome Proliferator–Activated Receptor-δ and Colonic Tumorigenesis
- (2009) Xiangsheng Zuo et al. JNCI-Journal of the National Cancer Institute
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- AMPK and PPARδ Agonists Are Exercise Mimetics
- (2008) Vihang A. Narkar et al. CELL
- Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease
- (2008) Jeffrey M. Peters et al. CLINICAL SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now